Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock
NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, in a $25.0 million public offering. The offering consists of 4,765,000 shares of common stock priced at $5.25 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Jeff Fessler and Marcelle Balcombe.
- Sichenzia Ross Ference LLP代表Avinger Inc.完成520万美元的承销普通股发行 - August 26, 2020
- Sichenzia Ross Ference LLP代表Roth Capital Partners，LLC作为独家账簿管理人完成Centrus Energy Corp.普通股的2,350万美元公开发行 - August 25, 2020
- Sichenzia Ross Ference合伙人Andrew M. J. Bernstein，Esq。将于2020年8月21日星期五下午2:00 – 4:00在纽约州律师协会2020年审判学院虚拟会议系列的下一部分中进行演讲：“大陪审团介绍和代表大陪审团中的客户”。 - August 18, 2020